Biotechnology Stocks
| # | Últimos 7 días | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 4528 | ABVC ABVC BioPharma, Inc. - Common Stock | 0.91 USD | +2.25% | +3.41% | -20.87% | -72.51% | 24.26 M USD | ||
| 4531 | ENLV Enlivex Ltd. - Ordinary Shares | 1.50 USD | +2.04% | -4.46% | -64.95% | +40.19% | 23.74 M USD | ||
| 4533 | MRKR Marker Therapeutics, Inc. - Common Stock | 1.52 USD | +9.35% | +29.91% | +25.62% | +17.83% | 25.34 M USD | ||
| 4534 | CELU Celularity Inc. - Class A Common Stock | 0.77 USD | -3.75% | +10.00% | -3.75% | -79.95% | 22.29 M USD | ||
| 4544 | ALLR Allarity Therapeutics, Inc. - Common stock | 1.39 USD | -2.11% | +1.46% | +16.81% | +49.46% | 22.12 M USD | ||
| 4546 | COCP Cocrystal Pharma, Inc. - Common Stock | 1.12 USD | -2.61% | -1.75% | +23.08% | -28.21% | 21.57 M USD | ||
| 4554 | KZIA Kazia Therapeutics Limited - American Depositary Shares | 13.25 USD | -1.19% | -1.19% | +4.66% | +126.50% | 21.45 M USD | ||
| 4561 | NEUP Neuphoria Therapeutics Inc. - Common Stock | 3.90 USD | -0.26% | +1.56% | +4.56% | -46.06% | 21.08 M USD | ||
| 4583 | PLUR Pluri Inc. - Common Stock | 1.70 USD | -7.61% | +1.80% | -5.03% | -55.50% | 18.34 M USD | ||
| 4592 | CALC CalciMedica, Inc. - Common Stock | 0.56 USD | -1.75% | -18.84% | -24.32% | -80.00% | 19.12 M USD | ||
| 4594 | RADX Radiopharm Theranostics Limited American Depositary Shares | 2.47 USD | +1.23% | -3.52% | -28.20% | -57.85% | 19.47 M USD | ||
| 4608 | CYCN Cyclerion Therapeutics, Inc. - Common Stock | 4.10 USD | +4.06% | +5.13% | +20.23% | +65.32% | 19.19 M USD | ||
| 4617 | LEXX Lexaria Bioscience Corp. - Common Stock | 10.42 USD | -4.58% | +11.32% | +1794.55% | +1186.42% | 17.22 M USD | ||
| 4632 | PTN Palatin Technologies, Inc. Common Stock | 10.14 USD | +4.64% | +4.43% | +31.35% | +39.86% | 18.04 M USD | ||
| 4635 | LPCN Lipocine Inc. - Common Stock | 2.07 USD | 0.00% | 0.00% | -0.96% | -28.62% | 17.07 M USD | ||
| 4648 | CTXR Citius Pharmaceuticals, Inc. - Common Stock | 0.59 USD | -1.67% | +3.51% | +18.00% | -55.97% | 16.20 M USD | ||
| 4651 | ADIL Adial Pharmaceuticals, Inc - Common Stock | 5.25 USD | -15.59% | +25.30% | +91.61% | +1281.58% | 13.79 M USD | ||
| 4653 | KALA KALA BIO, Inc. - Common Stock | 0.80 USD | -4.76% | -12.09% | +29.03% | -91.26% | 15.47 M USD | ||
| 4656 | HIND Vyome Holdings, Inc. - Common Stock | 2.29 USD | +0.44% | +5.05% | +11.17% | -80.19% | 16.07 M USD | ||
| 4662 | INTS Intensity Therapeutics, Inc. - Common Stock | 4.71 USD | -3.09% | +16.30% | +4.67% | +1470.00% | 15.38 M USD |
Noticias Biotechnology Stocks
Deutsche Bank rebaja argenx a Mantener por valoración
¿Por qué cae hoy la acción de Monte Rosa Therapeutics?
Las acciones de Biomea Fusion se disparan tras completar el ensayo sobre diabetes
Las acciones de Monte Rosa caen al inicio de un estudio de fase 2 contra el cáncer de próstata
Las acciones de Crinetics Pharmaceuticals alcanzan máximos históricos en 84,8 dólares
H.C. Wainwright reitera su calificación de Biomea Fusion tras inscripción en ensayo
La FDA amplía la revisión de deramiocel de Capricor hasta el 22 de noviembre
Gainers Biotechnology Stocks
SKYE Skye Bioscience, Inc. - Common Stock | 2.11 | +653.57% |
RCKTW Rocket Pharmaceuticals, Inc. - Warrant | 0.0038 | +280.00% |
ENGNW enGene Therapeutics Inc. - Warrants | 0.4301 | +71.90% |
NTRBW Nutriband Inc. - Warrant | 0.7500 | +50.00% |
OABIW OmniAb, Inc. - Warrant | 0.2339 | +37.59% |
LSTA Lisata Therapeutics, Inc. - Common Stock | 1.98 | +27.74% |
BMEA Biomea Fusion, Inc. - Common Stock | 1.68 | +22.63% |
CELG-RT Bristol-Myers Squibb Company Celegne Contingent Value Rights | 0.1098 | +19.09% |
Losers Biotechnology Stocks
HUMAW Humacyte, Inc. - Warrant | 0.0050 | -44.44% |
CINGW Cingulate Inc. - Warrants | 0.0060 | -34.07% |
RGNX REGENXBIO Inc. - Common Stock | 8.14 | -24.07% |
ADIL Adial Pharmaceuticals, Inc - Common Stock | 5.25 | -15.59% |
APLMW Apollomics Inc. - Warrant | 0.0111 | -13.95% |
BCTX BriaCell Therapeutics Corp. - Common Shares | 3.61 | -11.30% |
YDESW YD Bio Limited - Warrants | 0.3642 | -11.17% |
SNTI Senti Biosciences, Inc. - Common Stock | 0.35 | -10.26% |